share_log

白云山(600332.SH)分公司何济公药厂新增生产线和生产范围获批

The baiyunshan (600332.SH) branch company's Hejigong Pharmaceutical Factory has been approved for the addition of new production lines and expanded production scope.

Zhitong Finance ·  Nov 20 16:23

Baiyunshan (600332.SH) issued an announcement, the company's subsidiary Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., Baiyunshan...

Zhitong Finance APP News, Baiyunshan (600332.SH) issued an announcement, the company's subsidiary Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., Baiyunshan Hejigong Pharmaceutical Factory (referred to as "Hejigong Pharmaceutical Factory") received the "Drug Production License" approved and issued by the Guangdong Provincial Drug Administration, allowing Hejigong Pharmaceutical Factory to add production lines and production ranges, and passed the inspection of drug production quality management standards. Hejigong Pharmaceutical Factory is allowed to add a production line "Aerosol Production Line" and expand the production scope to "Aerosols" at the production workshop "Liwan Manufacturing Department", located at "No. 49 Liwan Road, Guangzhou".

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment